| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.37 | $101.15 (0%) | 🛒 Add to cart |
| 60 | $2.70 | $202.30 $162.24 (20%) | 🛒 Add to cart |
| 90 | $2.49 | $303.45 $224.33 (26%) | 🛒 Add to cart |
| 120 | $2.37 | $404.60 $284.42 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $606.90 $406.60 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $910.34 $590.87 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.07 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.61 $70.10 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.14 $91.13 (7%) | 🛒 Add to cart |
| 180 | $0.73 | $147.22 $132.20 (10%) | 🛒 Add to cart |
| 270 | $0.72 | $220.83 $195.29 (12%) | 🛒 Add to cart |
| 360 | $0.71
Best per pill | $294.43 $257.38 (13%) | 🛒 Add to cart |
Similar products
More info:
Diltiazem: Multimodal Cardiovascular Protection with Proven Efficacy
Diltiazem hydrochloride, available under brand names like Cardizem and Tiazac, represents one of the most versatile cardiovascular agents in our modern pharmacopeia. As a benzothiazepine derivative calcium channel blocker, it occupies a unique niche between the dihydropyridines like amlodipine and non-dihydropyridines like verapamil, offering what I’ve come to appreciate as the “Goldilocks profile” – not too vasoselective, not too cardiodepressant, but just right for many complex patients. When I first encountered diltiazem during my cardiology fellowship in the late 1990s, I’ll admit I underestimated its subtle sophistication, initially viewing it as merely another antihypertensive option.
adalat
Nifedipine, marketed under the brand name Adalat, represents a cornerstone in cardiovascular pharmacotherapy as a first-generation dihydropyridine calcium channel blocker. Initially developed by Bayer in the 1970s, this medication fundamentally altered hypertension and angina management by selectively inhibiting calcium influx into vascular smooth muscle and cardiac cells. The clinical significance of Adalat lies in its potent vasodilatory effects, which reduce peripheral vascular resistance without significantly affecting cardiac conduction—a pharmacological profile that made it particularly valuable for patients who couldn’t tolerate beta-blockers.
calan
Calan represents one of those interesting cases where a well-established cardiovascular medication found surprising applications beyond its original scope. As verapamil hydrochloride, it’s primarily known as a calcium channel blocker, but what fascinates me is how its mechanism translates across different clinical scenarios. I remember first encountering Calan during my cardiology rotation back in ‘98 - we were using it for angina and hypertension, but the electrophysiology team kept borrowing our supply for their afib patients.
cardizem
Cardizem, known generically as diltiazem, is a calcium channel blocker primarily prescribed for managing cardiovascular conditions such as hypertension, chronic stable angina, and certain arrhythmias like atrial fibrillation. It functions by inhibiting calcium ion influx across cardiac and vascular smooth muscle cell membranes, leading to coronary and peripheral vasodilation, reduced myocardial oxygen demand, and slowed atrioventricular nodal conduction. Available in immediate-release, extended-release, and intravenous formulations, Cardizem is a cornerstone therapy in cardiology due to its efficacy and relatively favorable side effect profile compared to other antianginal and antihypertensive agents.
Coreg: Comprehensive Heart Failure and Hypertension Management - Evidence-Based Review
Coreg, known generically as carvedilol, is a non-selective beta-blocker with additional alpha-1 blocking activity. It’s primarily used in cardiovascular medicine for managing conditions like heart failure, hypertension, and post-myocardial infarction. The unique dual mechanism sets it apart from traditional beta-blockers, offering more comprehensive adrenergic blockade. 1. Introduction: What is Coreg? Its Role in Modern Medicine Coreg represents a significant advancement in beta-blocker therapy, combining non-selective beta-adrenergic blockade with alpha-1 receptor antagonism.
digoxin
Digoxin, a cardiac glycoside derived from the foxglove plant (Digitalis lanata), represents one of medicine’s oldest yet most precisely targeted therapies for specific heart conditions. Initially used as a folk remedy for dropsy (edema), its modern application focuses primarily on managing atrial fibrillation and heart failure through its unique inotropic and chronotropic effects. Unlike many contemporary cardiovascular agents, digoxin’s narrow therapeutic index demands meticulous dosing and monitoring, making its clinical use both an art and a science.
Female Viagra: Evidence-Based Treatment for Hypoactive Sexual Desire Disorder - Comprehensive Review
When we first started seeing patients presenting with what we now recognize as hypoactive sexual desire disorder (HSDD) in premenopausal women, the clinical landscape was essentially barren. I remember sitting across from Sarah, a 38-year-old attorney with two young children, who described her situation with heartbreaking clarity: “It’s not that I don’t love my husband - I just don’t have any interest in sex anymore. It’s like that part of my brain just switched off.
inderal
Before we get to the formal monograph, let me give you the real picture on this one. I’ve been prescribing Inderal for nearly twenty years now, and it’s one of those drugs that separates the experienced clinicians from the textbook prescribers. The official documentation tells you it’s a beta-blocker for hypertension and angina, but the real clinical utility is so much broader - and sometimes trickier - than the package insert suggests.
innopran xl
Propranolol hydrochloride extended-release capsules – we’re talking about the 80mg, 120mg, 160mg strengths in those distinctive bottles. The formulation’s clever really, using a patented osmotic pump system that creates this steady-state plasma concentration for a full 24 hours. Funny story – when I first started using extended-release beta-blockers back in my residency, we had this patient, Mrs. Gable, 68 with persistent essential tremor that made her life miserable. She’d tried immediate-release propranolol but the peaks and troughs left her either too fatigued or still shaking.